ened neutralization escape.Overall, vaccine efficacy against BA.2.75 is expected to be similar to that against BA.1 and BA.2.Whether and by how much another vaccine booster, particularly one containing an omicron spike, would elicit a more potent response against BA.2.75 and future SARS-CoV-2 variants remains of high interest for vaccine development.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: